✦ LIBER ✦

Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia

✍ Scribed by Su Jin Lee; Chul Won Jung; Dae-Young Kim; Kyoo-Hyung Lee; Sang Kyun Sohn; Jae-Yong Kwak; Hyeoung-Joon Kim; In Ho Kim; Seonyang Park; Dong Hwan (Dennis) Kim

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 234 KB
Volume: 86
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.21980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dasatinib, even at low doses, is an effe

Dasatinib, even at low doses, is an effective second-line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life-based Italian multicenter retrospective study on 114 patients

✍ Giuseppe Visani; Massimo Breccia; Antonella Gozzini; Giorgina Specchia; Enrico M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB